BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12201934)

  • 1. The treatment of sphincter incontinence with periurethral silicone implants (macroplastique).
    Peeker R; Edlund C; Wennberg AL; Fall M
    Scand J Urol Nephrol; 2002; 36(3):194-8. PubMed ID: 12201934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic correction of intractable stress incontinence with silicone micro-implants.
    Sheriff MK; Foley S; Mcfarlane J; Nauth-Misir R; Shah PJ
    Eur Urol; 1997; 32(3):284-8. PubMed ID: 9358214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macroplastique implantation system for the treatment of female stress urinary incontinence.
    Tamanini JT; D'Ancona CA; Tadini V; Netto NR
    J Urol; 2003 Jun; 169(6):2229-33. PubMed ID: 12771756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of postoperative male urinary incontinence using transurethral macroplastique injections.
    Kylmälä T; Tainio H; Raitanen M; Tammela TL
    J Endourol; 2003 Mar; 17(2):113-5. PubMed ID: 12689406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study.
    Ghoniem G; Corcos J; Comiter C; Bernhard P; Westney OL; Herschorn S
    J Urol; 2009 Jan; 181(1):204-10. PubMed ID: 19013613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peri-urethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence.
    Harriss DR; Iacovou JW; Lemberger RJ
    Br J Urol; 1996 Nov; 78(5):722-5; discussion 726-8. PubMed ID: 8976767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
    Radley SC; Chapple CR; Mitsogiannis IC; Glass KS
    Eur Urol; 2001 Apr; 39(4):383-9. PubMed ID: 11306875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial.
    Maher CF; O'Reilly BA; Dwyer PL; Carey MP; Cornish A; Schluter P
    BJOG; 2005 Jun; 112(6):797-801. PubMed ID: 15924540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of stress urinary incontinence in women with urethral hypermobility and intrinsic sphincter deficiency.
    Kreder KJ; Austin JC
    J Urol; 1996 Dec; 156(6):1995-8. PubMed ID: 8911373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Periurethral injection of silicone microparticles in the treatment of sphincter deficiency urinary incontinence].
    Hidar S; Attyaoui F; de Leval J
    Prog Urol; 2000 Apr; 10(2):219-23. PubMed ID: 10857138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of transurethral injection of silicone micro-implants for females with intrinsic sphincter deficiency.
    Barranger E; Fritel X; Kadoch O; Liou Y; Pigné A
    J Urol; 2000 Nov; 164(5):1619-22. PubMed ID: 11025718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence.
    Imamoglu MA; Tuygun C; Bakirtas H; Yiğitbasi O; Kiper A
    Eur Urol; 2005 Feb; 47(2):209-13. PubMed ID: 15661416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral polydimethylsiloxane implantation: a valid option for the treatment of stress urinary incontinence due to intrinsic sphincter deficiency without urethral hypermobility.
    Zullo MA; Plotti F; Bellati F; Muzii L; Angioli R; Panici PB
    J Urol; 2005 Mar; 173(3):898-902. PubMed ID: 15711314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for periurethral collagen injection in the management of urodynamically proven mixed urinary incontinence?
    Poon CI; Zimmern PE
    Urology; 2006 Apr; 67(4):725-9; discussion 729-30. PubMed ID: 16618559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.
    Bano F; Barrington JW; Dyer R
    Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(2):147-50; discussion 150. PubMed ID: 15378234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transurethral injections under local anaesthesia for ambulatory treatment of stress urinary incontinence in women: indications, feasibility and results].
    de Tayrac R; Cortesse A; Fernandez H; Fritel X
    J Gynecol Obstet Biol Reprod (Paris); 2005 Nov; 34(7 Pt 1):702-10. PubMed ID: 16270009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contigen Bard Collagen implant: the Japanese experience.
    Yokoyama E
    Int J Urol; 1995 Apr; 2 Suppl 1():11-5; discussion 16-8. PubMed ID: 7614409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periurethral injection for the treatment of urinary incontinence.
    Benshushan A; Brzezinski A; Shoshani O; Rojansky N
    Obstet Gynecol Surv; 1998 Jun; 53(6):383-8. PubMed ID: 9618715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early experience with small volume periurethral polytetrafluoroethylene for female stress urinary incontinence.
    Herschorn S; Glazer AA
    J Urol; 2000 Jun; 163(6):1838-42. PubMed ID: 10799194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.